| scholarly article | Q13442814 |
| P2093 | author name string | Benigna Maria de Oliveira | |
| Marcos Borato Viana | |||
| Marcilene Rezende Silva | |||
| Maria Thereza Macedo Valadares | |||
| P2860 | cites work | Adherence to therapy with oral antineoplastic agents | Q28216182 |
| Attitude of health-care providers toward childhood leukemia patients with different socio-economic status | Q33293111 | ||
| Components of cure: treatment of acute lymphoblastic leukemia in Indonesia and other low-income countries | Q33371889 | ||
| Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia | Q33371891 | ||
| Thiopurine S-methyltransferase (TPMT) gene polymorphism in Brazilian children with acute lymphoblastic leukemia: association with clinical and laboratory data | Q33389798 | ||
| Recent advances in management of acute leukaemia | Q33930802 | ||
| Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia. | Q35280135 | ||
| Importance of 6-mercaptopurine dose in lymphoblastic leukaemia | Q35626568 | ||
| Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. | Q36402208 | ||
| Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet? | Q36662118 | ||
| Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review | Q36681895 | ||
| Why do doctors and patients not follow guidelines? | Q37458095 | ||
| How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolites | Q40398960 | ||
| Compliance with oral chemotherapy in childhood lymphoblastic leukaemia | Q40530116 | ||
| Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia | Q44381583 | ||
| Thiopurine methyltransferase in acute lymphoblastic leukemia | Q46886254 | ||
| Physician compliance and relapse rates of acute lymphoblastic leukemia in children | Q48106955 | ||
| Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. | Q55032992 | ||
| Acute lymphoblastic leukaemia | Q56722375 | ||
| LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia | Q59089540 | ||
| Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia | Q67840023 | ||
| Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood) | Q70219983 | ||
| Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia | Q73554165 | ||
| Treatment of pediatric acute lymphoblastic leukemia | Q81724967 | ||
| P433 | issue | 3 | |
| P921 | main subject | lymphoblastic leukemia | Q18553852 |
| P304 | page(s) | 185-189 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Revista brasileira de hematologia e hemoterapia | Q26842116 |
| P1476 | title | Compliance with a protocol for acute lymphoblastic leukemia in childhood | |
| P478 | volume | 33 |
Search more.